Professional Documents
Culture Documents
In hospitals, the forms are somewhat different and are referred to as medication orders. In a typical medication
order sheet, the orders and instructions are written by the physician in ink. Please refer to the sample on the next page.
The medication order generally contains the following information:
• Doses: including the quantity of a prescribed dose, the total number of doses prescribed, and the number of days the
prescribed medication will last.
• Compliance: the patient’s or caregiver’s compliance in meeting the prescribed directions for dosing.
• Drug concentration: the quantity of an active therapeutic ingredient to use to achieve the
desired drug concentration.
• Rate of drug administration: the quantity of drug administered per unit of time to meet prescribed
dosing schedule (e.g., mg/min, drops/minute, or mL/hr for the administration of an
intravenous fluid).
• Compounding: the quantities of active and inactive components to use in the extemporaneous
preparation of a pharmaceutical product, including the use of stock solutions and/or prefabricated
dosage units in the process.
• Chemical-physical factors: including calculations to make solutions isotonic, iso-osmotic, equimolar,
or buffered.
• Pharmacoeconomics: including medication costs, cost-benefit analysis, cost-effectiveness analysis,
alternative treatment plans, and medication pricing.
It is the responsibility of the pharmacist to ensure that each prescription and medication order received is correct in its form
and content; is appropriate for the patient being treated; and is subsequently filled, labeled, dispensed, and administered
accurately. In essence, each medication should be:
Note: Please make sure that you have mastered the different abbreviation!
CNAHS | College of Pharmacy Exclusive for CIT Pharmacy Students only! 1
#TeknoyPharmacist
PhCare 331: Hospital Pharmacy
Drug doses vary between drug substances; there are drugs that have small doses, some drugs have large
doses. The dose is based on its biochemical and pharmacologic activity, physical and chemical properties, dosage
form, route of administration, and several patient factors, such as patient’s age, weight, body surface area, general
physical health , liver and kidney functions, and the illness being treated.
Definition of terms:
Dose - the quantitative amount of a drug administered or taken by a patient for the intended medicinal
effect.
Single dose – the amount of a drug taken at one time.
Total dose – the amount of drug taken during the time-course of therapy.
Dosage regimen – the schedule of dosing such as; four times a day for 10 days
Usual adult dose – the amount of a drug that originally produces the medicinal effect intended in adults.
Usual pediatric dose – the amount of a drug that originally produces the medicinal effect intended in
infants or child patient.
Median effective dose - the amount of a drug that produces the desired intensity of effect in 50% of the
individuals tested.
Median toxic dose – the amount of a drug that produces toxic effect in 50% of the individuals tested.
Minimum effective concentration (MEC) – the minimum blood serum concentration of a drug that can
be expected to produce the drug‘s desired effects in a patient.
Minimum toxic concentration (MTC) – the base level of blood serum concentration of a drug that
produces dose-related toxic effects.
Priming or loading dose – the dose larger than the usual initial dose that may be required to achieve the
desired blood drug level.
Maintenance dose – dose which is similar in amount to usual doses, and administered according to the
dosage regimen to sustain the desired drug blood levels or drug effects.
Prophylactic dose – a dose that protects the patient from contracting a specific disease.
Therapeutic dose - a dose that counter a disease after exposure.
Pediatric Dosage
Pediatrics is the branch of medicine that deals with disease in children from birth through adolescence.
A number of factors affect the proper dosing of drugs for pediatric patients which include the age and weight of
the patient, over all health status, the condition of biologic functions (e.g., respiration and circulation), and the
Pharmacokinetic data (i.e., the rates and extent of drug absorption, distribution, metabolism, and elimination)
together with individual patient drug handling characteristics, and therapeutic response, are important in the
calculation of doses for pediatrics.
The following equations are useful in the calculation of dose based on body surface area is:
1.73 m²
3600
References:
Ansel, Howard . 2010. Pharmaceutical Calculations. 13th edition. Philadelphia, Walnut Street: Lippincott Williams and Wilkins.
Brown, T. (2010). Introduction to Hospital and Health-System Pharmacy Practice. Bethesda: American Society of Health-System
Pharmacists
Gennaro, A. et.al. (2000). Remington’s Pharmaceutical Sciences, 20th ed., 2000, Pennsylvania: Mack Publishing Company.
• Clark’s Rule
(Weight in pounds/150) (adult dose) Dosage Form
Supply Dosage
• Fried’s Rule
(Age in months/15) (adult dose)
• Cowling’s Rule
(Age in the next birthday/24) (adult dose)
Label Alert
Name of Manufacturer
Expiration Date
Lot Number
NDC Code
Control Substance Schedule
Powder Form Drugs for Parenteral Use and for Oral Solution or Suspension
Drug manufacturers prepare some drugs, especially antibiotics, in dry powder form, since these drugs lose their
potency in a short period of time when they are in liquid form. These preparations need to be reconstituted with a
specific solvent such as purified water for oral use, and sterile water for injection, bacteriostatic water for injection,
0.9% sodium chloride injection, or other specific solvents for parenteral use, as stated on the label of the drug
product or on the drug insert. They are reconstituted at the time a prescription or a medication order is received.
These preparations are available for both parenteral and for oral use.
Parenteral Use
The parenteral products contain only limited amount of specified added ingredients to increase stability and
effectiveness ( no colorants, flavorants, sweeteners, etc.are added). So, the bulk volume of the dry contents of a
vial is largely or entirely the medication. Generally, these medications are small-volume products intended for use by
injection or as additives to large volume parenterals.
If the dry powder, because of its small quantity, does not significantly contribute to the final volume of the
constituted solution , the volume of the solvent used will approximate the final volume of the solution. For example,
if 1000 units of dry drug powder are to be dissolved , and if the powder does not account for any significant portion
of the final volume, the addition of 5- mL solvent produces a solution containing 200 units / mL.( Stoklosa and Ansel)
If the dry powder is bulky, and it contributes to the final volume of the constituted solution, the increase in volume
produced by the drug must be considered, which is then be used in calculating the amount of solvent needed to
prepare a solution of a desired concentration. For example, a vial containing 1 G of dry powder of streptomycin
sulfate needs 4.2 mL of sterile solvent to be added to the dry powder to produce 5 mL of a solution which contains
200 mg./ mL. The drug accounts for 0.8 mL of the final volume.
Parenteral ( Gk, para enteron, beside the intestine) dosage forms are injected directly into body tissues
through the primary protective system of the human body, skin, and mucous membranes. Parenteral medications
must be sterile and free from pyrogens and particulate matter. Pyrogens are fever-producing organic substances
arising from microbial contamination and are responsible for many of the febrile reactions which occur in patients
following intravenous injection.
Most parenteral medications are prepared in liquid or solution form and packaged in vials, ampules, or
prefilled syringes. Vials are glass or plastic containers closed with a rubber stopper and sealed with an aluminum
crimp. Ampules are glass containers which have a neck portion with a score line. The score line is used as a guide in
breaking the glass to separate it from the body of the container, without producing any fragments of the glass. Any
unused portion of the opened ampule must not be used at a later time, since the sterility of the contents becomes
questionable already.
Hypodermic syringes are used to administer parenteral medications. Its capacity usually ranges from 2- to
50-mL capacity. Disposable hypodermic syringes are also available. They are mostly used outside of a hospital
setting.
The first crude instrument for parenteral therapy or injection of medication under the skin was a needle
trocar, developed to deposit morphine in paste form.
Tuberculin syringe is a small syringe not exceeding 1 mL in capacity and graduated in 0.1- or 0.01- mL
divisions.
Insulin syringe is a syringe calibrated in units and used in the administration of insulin.
Needles are also called cannulas. Hypodermic needles have been made of stainless steel, hyperchrome steel,
chromium, nickeloid, platinum, platinum-iridium, silver, or gold. A long-bevel or long- taper needle is used for local
anesthesia, aspirating, hypodermoclysis, and subcutaneous administration. A short-bevel needle is used for
intravenous administration, infusions, and transfusion. A special short-bevel needle is employed for intradermal and
spinal administration.
Regular needles are measured for length from where the cannula joins the hub to the tip of the point (hub not
included).
Intravenous (IV) infusions are sterile, aqueous preparations administered intravenously in relatively large
volumes. They are used to extend blood volume and/or provide electrolytes, nutrients, or medications. Most
intravenous infusions are administered to critical care, infirm, dehydrated, or malnourished patients, or to patients
prior to, during, and/or following surgery. Intravenous infusions are widely employed in emergency care units, in
hospitals and other patient care;
In common usage are macro sets that deliver 10, 15, or 20 drops per milliliter and microdrip or minidrip sets that deliver 60 drops
per milliliter.
• Isolator Additives
- Controlled environment defined by fixed walls, - Injections packaged in ampules or vials.
floors, and ceiling. - Or sterile solids (reconstituted)
- Transfers of materials into and out of the
environment are separated by barriers such as
gloves, sleeves, and airlocks. Procedure when adding additives:
- Inside is a negative pressure. 1. Fresh, sterile, disposable syringe is used for
- Personnel access the inside via the glove ports. each additive (single-use only).
- Used to conduct: 2. Before removing measured volume, wipe the
➔ Aseptic filling operations container with disinfectant solution.
➔ Sterility testing
➔ Cell culturing
➔ Purification activities Parenteral Incapability
• Physical Incompatibility
• Clean Room - Detected by changes in appearance (color,
- Room in which the concentration of airborne formation of precipitate, evolution of gas).
particles is controlled to meet a specified
airborne particulate cleanliness class.
- Microorganisms are monitored. • Chemical Incompatibility
- Decomposition of drug substance.
• Ante area/Anteroom - Mostly result from hydrolysis, oxidation,
- Area adjacent to buffer room/clean room. reduction, or complexation.
- Unsterilized products, in-process components, - Detected only with a suitable analytic method.
materials, and containers are handled.
• Therapeutic Incompatibility Products requiring special handling:
- Most difficult to observe. a. Controlled substances (schedule III)
- Results in undesirable antagonistic or synergistic b. Investigational drugs
pharmacological activity. c. Compounded products
- Example: Penicillin antagonizes the effect of d. Repackaged pharmaceuticals
Heparin e. Non-formulary items
f. Medication samples.
Receiving Deliveries
- Name & address
- Cold storage
- Missing, damaged, expiration date, consistency,
seal
- Newly delivered (p.o. receiving copy)
- Not ordered, not received, excess
- signature
Warehousing
- stability protected
• storage requirements (based on USP-NF)
• temperature (monitored daily)
• deliveries (proper location within 24 hours)
• primary label (in front)
• easy accessibility
- arranged alphabetically or by therapeutic
arrangement or by company
- stored off the floor
- monthly inspection
• instability
• clarity
• crystallization
• sedimentation
- assigned personnel (quarterly inspection)
- Separate room for:
• Corrosive
• Highly volatile
• Radioactive
- FEFO, FIFO
- Expiring (highlighted) → “stock rotation” (used of
products before they expire.
- Don’t deliver if:
• Expired
• Recalled
• Improperly stored
- Sound-alike, look-alike, misleading labels
• Color-coded labels
• Not adjacent